Celldex Therapeutics Inc (CLDX)
36.49
-0.53
(-1.43%)
USD |
NASDAQ |
Apr 25, 10:41
Celldex Therapeutics Free Cash Flow (Quarterly): -33.20M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.20M |
| September 30, 2023 | -19.15M |
| June 30, 2023 | -27.61M |
| March 31, 2023 | -29.15M |
| December 31, 2022 | -22.00M |
| September 30, 2022 | -35.54M |
| June 30, 2022 | -22.92M |
| March 31, 2022 | -25.11M |
| December 31, 2021 | -14.88M |
| September 30, 2021 | -16.56M |
| June 30, 2021 | -12.07M |
| March 31, 2021 | -18.65M |
| December 31, 2020 | -5.458M |
| September 30, 2020 | -12.02M |
| June 30, 2020 | -12.13M |
| March 31, 2020 | -12.34M |
| December 31, 2019 | -11.10M |
| September 30, 2019 | -11.28M |
| June 30, 2019 | -11.34M |
| March 31, 2019 | -13.42M |
| December 31, 2018 | -15.59M |
| September 30, 2018 | -14.45M |
| June 30, 2018 | -17.73M |
| March 31, 2018 | -28.28M |
| December 31, 2017 | -19.71M |
| Date | Value |
|---|---|
| September 30, 2017 | -24.64M |
| June 30, 2017 | -21.73M |
| March 31, 2017 | -35.64M |
| December 31, 2016 | -20.99M |
| September 30, 2016 | -24.76M |
| June 30, 2016 | -34.60M |
| March 31, 2016 | -35.44M |
| December 31, 2015 | -14.15M |
| September 30, 2015 | -29.15M |
| June 30, 2015 | -26.31M |
| March 31, 2015 | -34.15M |
| December 31, 2014 | -22.38M |
| September 30, 2014 | -27.26M |
| June 30, 2014 | -21.76M |
| March 31, 2014 | -32.07M |
| December 31, 2013 | -17.28M |
| September 30, 2013 | -18.44M |
| June 30, 2013 | -18.81M |
| March 31, 2013 | -17.36M |
| December 31, 2012 | -13.44M |
| September 30, 2012 | -11.02M |
| June 30, 2012 | -12.04M |
| March 31, 2012 | -13.60M |
| December 31, 2011 | -9.476M |
| September 30, 2011 | -8.18M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-35.54M
Minimum
Sep 2022
-5.458M
Maximum
Dec 2020
-18.55M
Average
-16.56M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | -2.235M |
| Perspective Therapeutics Inc | -9.097M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |
| Asensus Surgical Inc | -13.45M |